Dünya Sağlık Örgütü, 2020 yılının ilk günlerinde, dünyanın potansiyel pandemi ajanı olan yeni bir koronavirüs ile karşı karşıya olduğunu bildirmiştir. Etiyolojik ajanı Coronaviridae ailesinden, 2002 yılı Kasım ayında yine Çin’de ortaya çıkan SARS-CoV ile aynı alt aileye...

COVID-19 may cause another world-wide epidemic. This study is divided into 2 arms: (1) Prospective longitudinal observational study involving patients with laboratory-confirmed COVID-19 and (2) Retrospective study on patients with laboratory-confirmed COVID-19. Arm 1: W...

Updated dataset percent differences in codon usage spike and non-spike genes comparing to reference sequence of SARS-CoV-2. Fixed multiple grouping of different assemblies in same input files.<br>

Updated dataset % differences in codon usage between spike gene and all other genes from 5064 sequences compared to reference sequence. Corrected references.<br>

The investigators aim to characterise Coronavirus Disease 2019 (COVID-19) in every age group. On the one hand, emphasis is put on the initial presentation, clinical course, outcome and the therapy used. On the other hand further investigations regarding viral and bacter...

Le monde est confronté à une grave pandémie nommée COVID-19 due au nouveau virus SARS-CoV-2, qui a commencé en Chine en décembre 2019. Le COVID-19 peut être particulièrement grave et mortel dans certains groupes tels que les personnes âgées ou présentant certaines comor...

There is no specific antiviral therapy recommended for coronavirus disease 2019 (COVID-19). In vitro studies indicate that the antiviral effect of chloroquine diphosphate (CQ) requires a high concentration of the drug.To evaluate the safety and efficacy of 2 CQ dosages ...

This is a small pilot study investigating whether there is any efficacy signal that warrants a larger Phase 2B trial, or any harm that suggests that such a trial should not be done. It is not expected to produce statistically significant results in the major endpoints. ...

Healthcare workers are particularly at risk of SARS-CoV-2. In the absence of a vaccine, other strategies aiming to reduce the development of COVID-19 in the population, more specifically in healthcare workers is being sought. Administration of effective drugs to people ...

The Galaxy Community and ELIXIR had organised a webinar available here series to demonstrate how open software and public research infrastructures can be used in analysing and publishing SARS-CoV2 data. Best practices for the analysis of this data were presented for Gen...